| Names | |
|---|---|
| Preferred IUPAC name | 3-Hydroxy-2-methylbutanoate |
| Other names | 2-Hydroxyvalerate 2-Hydroxyvaleric acid DL-2-Hydroxyvaleric acid DL-2-Hydroxyvalerate |
| Pronunciation | /tuː haɪˌdrɒk.siˈvæl.əˌreɪt/ |
| Identifiers | |
| CAS Number | 626-72-0 |
| Beilstein Reference | 1209027 |
| ChEBI | CHEBI:36597 |
| ChEMBL | CHEBI:38449 |
| ChemSpider | 134735 |
| DrugBank | DB04248 |
| ECHA InfoCard | ECHA InfoCard: 100.032.380 |
| EC Number | 1.1.1.237 |
| Gmelin Reference | 7503 |
| KEGG | C02926 |
| MeSH | D000432 |
| PubChem CID | 11989 |
| RTECS number | YG7525000 |
| UNII | E8M7B7SZR5 |
| UN number | 2811 |
| Properties | |
| Chemical formula | C5H10O3 |
| Molar mass | 118.13 g/mol |
| Appearance | White solid |
| Odor | Odorless |
| Density | 1.046 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -1.0 |
| Vapor pressure | 0.0127 mmHg (at 25 °C) |
| Acidity (pKa) | 4.87 |
| Basicity (pKb) | 2.99 |
| Refractive index (nD) | 1.4270 |
| Viscosity | 1.378 cP at 25 °C |
| Dipole moment | 2.67 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 260.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -576.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -701.5 kJ/mol |
| Hazards | |
| Main hazards | May cause respiratory and skin irritation. |
| GHS labelling | GHS07; Warning; H315, H319, H335 |
| Pictograms | GHS06, GHS08 |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. |
| NFPA 704 (fire diamond) | 1-2-0 |
| Flash point | Flash point: 110 °C |
| Lethal dose or concentration | Lethal Dose (LD50) for 2-Hydroxyvalerate: "LD50 (oral, rat) > 2000 mg/kg |
| LD50 (median dose) | LD50: Rat oral 3730 mg/kg |
| NIOSH | ST5127000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 50-200 mg/L |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | 2-Hydroxyisovalerate 3-Hydroxyvalerate 2-Hydroxybutyrate Valeric acid |
| Category | Details |
|---|---|
| Product Name & IUPAC Name |
Product Name: 2-Hydroxyvalerate IUPAC Name: 2-hydroxypentanoic acid |
| Chemical Formula | C5H10O3 |
| Synonyms & Trade Names |
|
| HS Code & Customs Classification |
HS Code: Reference assignment as per chemical identity: typically listed under 2918.19 for carboxylic acids with additional oxygen; actual tariff subheading may shift based on local regulation and whether product is shipped as monomer, salt, ester or as a PHA copolymer component. Customs Considerations: Correct HS assignment often requires confirming if material is in pure acid, ester, or polymeric format. Shipment documentation must specify chemical form and intended industrial use for accurate customs declaration. |
2-Hydroxyvalerate production begins with route selection: fermentation-based synthesis from renewable feedstocks (e.g., mixed cultures metabolizing propionate/valerate precursors), or through controlled oxidation of valeric acid derivatives. Each route delivers a unique impurity profile; fermentation introduces organic acid residuals, while synthetic oxidation introduces cyclic derivatives and potential over-oxidation byproducts. Analytical verification focuses on residual starting material and enantiomeric purity for chiral grades.
Polyhydroxyalkanoate (PHA) formulations containing 2-hydroxyvalerate units require tight monomer ratio control. Downstream polymerizate functionality, freeze-thaw stability, and thermal processability all reflect 2-hydroxyvalerate content. Manufacturers validate lots with acid number, residual monomer, and molecular weight distribution using gel permeation chromatography (GPC)—tailored to customer process schemes.
Material intended for pharmaceutical or food-contact applications must pass additional lot release criteria for trace solvent and heavy metal residues. Industrial grades, often supplied in bulk for PHA co-polymerization, are qualified for color, odor, and flowability; these can drift with extended storage or sub-optimal packaging.
In the warehouse, 2-hydroxyvalerate in monomeric or low-molecular forms requires airtight containment to limit hydrolysis or oxidative yellowing; PHA-bound material presents lower reactivity risk, but moisture ingress control remains a primary concern for both performance and process safety on the customer side.
End users working with 2-hydroxyvalerate derivatives in polymer, biodegradable plastics, or specialty chemicals look for predictable quality on batch-to-batch supply and robust technical support for troubleshooting process variability.
In commercial production, 2-hydroxyvalerate usually appears as a colorless to pale yellow crystalline solid or viscous liquid, depending on purity and water content. Pure material tends not to emit a strong odor, though minor byproduct traces from certain synthesis routes may impart a faint, organic scent. Melting and boiling points shift based on grade and residual water. Laboratory-purified samples display melting behavior in line with literature values, but bulk technical grades often show depressed or broad melting ranges due to minor impurities and moisture absorbed during handling or storage. Vendors and downstream formulators rely on batch-specific characterization for critical applications like polymers or life science intermediates, since color, clarity, and flow properties all respond to both grade and aging.
Hydroxy acids, such as 2-hydroxyvalerate, show stability in cool, dry environments, but the molecule is prone to lactonization and self-esterification above room temperature or under acidic or basic conditions. Hydrolytic degradation may proceed slowly in high humidity or aqueous solution, which also facilitates racemization if stereochemical integrity is required. Storage under inert gas and avoidance of strong oxidizers or reducing agents protect product specifications for customers with high-purity requirements, especially in pharmaceutical and polymer sectors.
Solubility varies by solvent and by the presence of cations. Water solubility is moderate and fluctuates with pH due to ionizable carboxyl functionality. Alcohols and polar organic solvents are generally effective for making concentrated stock solutions; some agglomerate formation can occur during dissolution depending on grade and pre-treatment of the batch. Formulators working at plant scale often rely on specialized dispersion protocols to avoid seeding, precipitation, or partial hydrolysis. No standard preparation method suits all scenarios—laboratories may employ gentle warming or neutralization, whereas process-scale makeup emphasizes agitation and solvent choice as determined by downstream usage.
Grades reflect application focus: technical, reagent, or pharmaceutical—each defined according to customer need, region, or internal QC. Purity, color, water content, and enantiomeric excess represent key differentiators. Test values provided in COAs represent batch averages, but release specifications depend on end use and route of manufacture.
| Grade | Purity | Water | Color (APHA/Hazen) | Stereochemistry |
|---|---|---|---|---|
| Technical | Typical value, not less than 95% | Process-dependent | May range from colorless to light yellow | Rarely specified |
| Reagent | Higher purity, typically above 98% | Strictly controlled below standard limits | Transparent/colorless preferred | Achiral or defined racemate |
| Pharmaceutical | Highest purity, customer-defined | Dehydrated or specified by analysis | Very low APHA/Hazen indices | Chiral purity as determined by process |
Impurities arise from incomplete conversion, side reactions (especially during lactonization), raw material origins, or process solvents. Profiles include unreacted valeryl precursors, oligomers, byproduct carboxylic acids, and trace metals depending on catalyst or vessel type. For customers with stringent bioactivity or polymerization requirements, detection and quantification employ HPLC, GC, and ICP techniques. Acceptable impurity content is never universal—each sector sets its own tolerances based on application risk.
Methods mirror product grade: titration for acid content in bulk grades, chiral HPLC for enantioselective intermediates, Karl Fischer titration for water, spectrophotometry for color. International or regional pharmacopeias, ISO procedures, or customer-provided methods may serve as reference, but internal validation remains necessary to guarantee batch-to-batch reliability during scale-up or supply to regulated markets.
Common synthetic access routes utilize valeric acid or its esters as starting feedstock. Raw material selection weighs economic, regional, and regulatory considerations—biobased routes can be prioritized for high-value or sustainability-focused supply chains, whereas commodity manufacture gives weight to local chemical market pricing and logistics.
Hydroxylation steps proceed by chemical or biocatalytic means. Traditional processes use oxidants or metal catalysts for direct functionalization, sometimes via intermediate lactone formation. The pathway chosen reflects environmental requirements, cost targets, and target specification (especially chirality). Multistep routes may favor controlled temperature profiles and pH regimes to limit breakdown, side formation, or color body development.
Critical control points include temperature ramping and reaction completion monitoring to avoid byproduct build-up. Intermediate workups often involve extraction, distillation, crystallization, or ion-exchange steps—each selected for the impurity burden and downstream use. For applications requiring high purity or stereo-specificity, advanced chromatographic or membrane filtration techniques supplement bulk purification.
In-process analytics check intermediate composition, impurity carryover, solvent residues, and color. Final batch release hinges on QC data for purity, identity, water content, and, if relevant, chiral purity. Customer-driven specifications may demand additional release criteria, especially for regulated markets or specialty applications; manufacturers tailor batch release protocols to application and contractual obligations.
2-Hydroxyvalerate enters into esterification, amidation, and lactonization reactions—especially under acid or base catalysis. It also undergoes polymerization with compatible comonomers to form polyhydroxyalkanoates or resins suitable for biodegradable plastics and intermediate uses in materials science.
Reaction efficiency and selectivity shift with catalyst choice, temperature, and solvent. Acid catalysis suits rapid esterification, but polymer-grade purity may require base-neutral or biocatalytic steps to limit side reactions. Choice of conditions must factor desired downstream molecular weight or chiral integrity.
Derivatives arise via acylation, transesterification, and subsequent polymerization. Applications dictate modifications—drug intermediates may require enantiomerically pure esters; plastics industry customers seek oligomer or homopolymer formation using controlled catalysts and processing temperature regimes.
Product longevity depends on avoidance of high humidity, prolonged exposure to light, and ingress of oxygen—these promote color formation and polymerization. Preferred practice involves storage in sealed, opaque containers under inert gas, especially for sensitive grades or large inventory holds.
Standard containment employs glass or compatible polymer drums and intermediate bulk containers. Contact with reactive metals or some engineering plastics can leach or catalyze unwanted degradation, especially for high-purity pharmaceutical grades or stock solutions. Container choice ties back to downstream product handling, transport temperature, and anticipated static times.
Shelf life varies by grade and storage control. Typical degradation indicators include yellowing, viscosity increase, appearance of insoluble particulates, or off-odors. Laboratories and warehouse managers monitor stocks for these markers—any sign prompts corrective handling or requalification per batch management SOP.
GHS classification, hazard, and labeling depend on purity, concentration, and regional requirements. The hydroxy acid structure carries recognized risks for skin and eye irritation at concentrated or technical grades, but data gaps may exist for chronic exposure or high-dose acute toxicity for less common homologs.
Handling at industrial scale calls for chemical splash goggles, gloves, local exhaust, and avoidance of prolonged skin contact. Ventilation, spill management, and first aid protocols follow local regulation and plant SOP. Technical staff receive regular hazard communication updates as new supplier or customer data emerges. For non-routine work or large volume transfer, site-specific risk assessments govern controls.
Quantitative toxicological studies are more complete for short-chain analogs, so process chemists and EH&S teams extrapolate handling guidelines with caution. Operators rely on air monitoring, batch log tracking, and exposure assessments tailored to process steps. Personnel controls aim to limit inhalation and direct skin exposure, with process design favoring containment and automation in dedicated facilities. Customers with sensitive downstream uses (cosmetic, medical device, or active pharmaceutical intermediate) specify further controls based on application hazard and current toxicological consensus.
Annual capacity for 2-Hydroxyvalerate follows adjustments in downstream demand, driven by requirements from pharmaceutical, biochemical, and specialty polymer sectors. Multi-ton batches rely on reliable sourcing of starting valeric acid or precursor aldehydes. Actual availability ties closely to client grade requirements and compliance needs—pharma/intermediate, technical, or research grade. Raw material fluctuations force periodic recalibration of order acceptance and campaign scheduling to protect both batch integrity and minimum economic batch size.
Lead time for standard technical grades remains 3-4 weeks under stable feedstock contracts. High-purity or regulatory-compliant grades extend production cycles due to extended purification and batch-wise validation. Minimum order quantity often follows reactor size, packaging line thresholds, and downstream logistics costs—typically quoted following end-use disclosure and verification of compliance controls.
Packaging depends on product grade and shipping regulations. Technical grades move in drum or intermediate bulk container (IBC). Pharma, food contact, or high-purity lots use double-lined HDPE containers or stainless drums, involving tamper-evident seals and certificates of conformance. Packaging selection considers stability studies against moisture ingress and material compatibility, as hydroxy acids display water sensitivity in open exposure.
Shipping terms generally follow INCOTERMS, negotiated by geography and compliance requirement (hazardous vs. non-hazardous labeling, MSDS support, ADR/IATA classification). Payment options range from TT advance for small-lot custom synthesis to credit arrangements for established industry buyers following creditworthiness review. Test samples or pilot lots are typically prepaid absent a longstanding relationship.
Raw material costs for 2-Hydroxyvalerate center on valeric acid or derived intermediates, hydrogen sources, solvents, and purification reagents. Volatility in upstream n-pentanol, aldehydes, or fermentation feedstock drives cost base swings. Catalysts and specialty adsorbents, required for high-purity grades, introduce step-change costs not always present in standard technical output. Yield efficiency, solvent recoverability, and off-gas venting limitations weigh on per-batch spend.
Feedstock market pricing responds to crude oil and agricultural byproduct cycles, particularly in Asia and EU supply basins. Disruptions in logistics, plant shutdowns, or regulatory testing backlogs cause localized price spikes or availability bottlenecks. For high-purity applications, additional filtration media and certified downstream solvents shift finished product cost depending on batch testing or rework demand.
Grade segmentation—technical, analytical, pharmaceutical—drives pricing as release testing, documentation, and batch record retention add layers to cost. Certifications or dossiers for regulatory markets (GMP, REACH, FDA) build compliance surcharges into contract rates. Purity, certification scope, and required impurity profiling arrange a multi-tiered pricing structure aligned with downstream audit requirements.
Product grade and certification requirements dictate most price variance. Technical grade draws from main production campaigns with minimal downstream purification, while pharma and food-contact lines undergo extra decontamination, multiple process holds, and batch-spec verification, raising both labor and material overhead by a considerable margin. Packaging certified for regulated commerce (cleanroom, traceable lot codes) introduces further cost compared to general industrial bulk drum shipments.
Demand for 2-Hydroxyvalerate tracks polymer R&D, specialty chemical, and pharma intermediate manufacturing cycles. China and the US remain the largest users for polymer and biotransformation applications, while the EU features stringent compliance needs. Production expansion closely trails downstream licensing or end-product regulatory approvals, particularly for medical, food, and biochemical use cases.
| Region | Supply Situation | Demand Drivers |
|---|---|---|
| US | Stable, with some feedstock impact from domestic petrochemicals. | Advanced polymers, pharma intermediates, research sector. |
| EU | Constrained by REACH, focused on certified grades. | High-purity, compliance, circular polymer initiatives. |
| JP | Niche market, specialty synthesis. | Precision intermediates, project-based contracts. |
| IN | Developing supplier base, variable availability. | Generic pharma, emerging polymer production. |
| CN | Large-scale output, variable reliability across grades. | Bulk intermediates, polysynthetic applications, export. |
Price direction for 2026 reflects tightening global compliance expectations, continued volatility in feedstock supply, and greater pressure on traceable, certified output. High-purity and regulatory-compliant grades expect substantial premium over bulk technical output, particularly as downstream customers shift toward green chemistry profiles and audited supply chains. New capacity in Asia and incremental upgrades in Europe may temper cost increases, but price differentiation between technical and compliance-driven lots will continue to widen unless raw material volatility or plant shutdowns ease.
Forecasts combine internal batch costing, market intelligence reports, and cross-validation with customer order trends. Regulatory update monitoring, raw material feed negotiations, and custom synthesis quote histories inform supply and price projection, particularly for grades subject to trace certification and regulatory batch-testing.
Pharma and biopolymer industries increasingly specify higher grades for novel applications, pushing supply chains to provide batch-specific testing and full impurity profiles. Increased scrutiny on sustainable sourcing and carbon footprint reporting has begun to affect procurement criteria from major international buyers.
REACH and FDA registration efforts prompt longer lead-time for certain grades. Regulatory reporting now requires extended batch dataset retention and transparency on intermediates, particularly for higher-volume or pharmaceutical-bound output. Compound dossiers must reflect any adjustment to feedstock route, catalyst batch, or downstream processing steps.
Production teams focus on investment in in-line analytics and traceable batch control to meet evolving compliance requirements. Process calendar optimization limits raw material exposure risk. Continuous re-evaluation of source auditing and alternative feedstock options forms the risk mitigation core. Technical support collaborates with clients to match material grades to end-use, optimize MOQ, and define packaging configurations to minimize regulatory or transport disruption.
2-Hydroxyvalerate delivers unique characteristics for several sectors, especially biopolymer intermediates, specialty esters, and pharmaceutical research. End users rely on its branching and hydroxyl functionality to modulate polymer flexibility or tailor precursor chemistry. The core user base includes formulators of polyhydroxyalkanoates (PHA), intermediates for biodegradable plastics, and select drug synthesis intermediates.
| Application | Grade Category | Key Focus Parameters |
|---|---|---|
| PHA Biopolymer Synthesis | Polymer-grade | Residual acids, moisture, trace metals |
| Specialty Ester Formation | Esterification-grade | Color, acidity, volatile organics |
| Pharmaceutical Intermediate | API-intermediate grade | Purity profile, individual impurity tracking, endotoxin risk |
Polymer applications direct attention to low levels of catalyst poisons and high purity. In ester chemistry, consistent color and limited acid value affect downstream stability. For pharmaceutical intermediates, each batch runs through targeted impurity tracking based on applicable regional regulatory requirements. Customers in regulated markets often specify additional needs for elemental impurity screening and biological burden testing.
Match your end-use to the closest grade type. Biopolymer producers report the most difficulty with batch-to-batch variation in contaminants that affect catalyst performance. Pharmaceutical clients prioritize trace impurity profiles and require supporting technical documentation.
Traceability practices differ across sectors. For API intermediates, adherence to pharmacopeial standards or customer’s own specifications governs both impurity profile acceptance and batch release. Polymer-grade clients may focus more on technical suitability, with environmental and health safety data provided upon request. End-user declarations often determine which additional audits or certification processes become necessary.
Purity targets result from both application demands and downstream process sensitivity. Lower-level contaminants arise from side reactions or handling equipment. Custom purification steps, such as multi-stage distillation or recrystallization, reduce off-spec impurities when tighter controls are needed. Select the lowest impurity threshold compatible with downstream requirements.
Volume requirements impact both packaging and qualification options. High-volume polymer users often shift to bulk grade after trial batches. Sourcing for pharmaceutical trials favors smaller lots with full trace-level impurity reporting. Budgetary constraints sometimes require balancing grade stringency with achievable process control, as excess specification leads to higher production cost per batch.
Final confirmation requires real-world trial. Typical industry practice includes requesting representative material from routine production, not pilot demonstration, to ensure process reality. Users typically benchmark analytical results against their own acceptance criteria, with manufacturers offering technical support for troubleshooting and adjustment where outliers occur.
Operational priorities for 2-Hydroxyvalerate start with system-level control. Our manufacturing sites implement ISO-based quality management systems that address end-to-end documentation, traceability, and risk mitigation. Audits and validation occur at regular intervals. Certification status remains current to ensure direct supply chain acceptance in regulated applications. The specific scope of certification aligns with both product category and the typical demands of downstream pharmaceutical, biotech, or chemical process stakeholders. Internal process mapping focuses on critical control points—purity checks, raw material vetting, and real-time process monitoring—helping to prevent cross-contamination and unauthorized deviation.
Requirements for 2-Hydroxyvalerate depend on the final application. Pharma-grade and food-contact requests trigger tighter batch documentation, with process validation centered on absence of restricted residuals, adherence to allergens protocols, and route-specific impurity profiling. Exact certifications—such as GMP, food-grade declarations, or REACH registrations—are issued on a per-lot or per-order basis, subject to supporting analytical files and assurance cycles. Each request receives a review to check for region-specific or customer-driven compliance frameworks.
Every batch is released only after multi-point quality assessment. Standard deliverables include Certificate of Analysis citing in-process and release test points, batch traceability documents, and custom regulatory compliance declarations as needed. Quality benchmarks adjust based on grade: technical, feedstock, research, or pharmaceutical. Where customers require deeper trace sequencing, extended audit packs or validation master plans can be made available following review. Ongoing improvements to analytical coverage reflect observed customer demands in fermentation, synthesis, and purification outcomes.
2-Hydroxyvalerate production relies on strategically sourced precursors and in-house process engineering. Key feedstocks receive supplier vetting with contingency provisions for multi-source backup. Scale-up is managed through modular batch trains or continuous processing routes depending on volume triggers. Advance capacity booking and agreed rolling forecasts from customers allow more reliable long-term supply. The business model supports standard bulk, small-lot, and just-in-time consignment options to accommodate variable buyer needs, especially where end users operate with fluctuating demand profiles.
Process intensification and yield optimization are continuously reviewed and implemented in response to seasonal or market-driven raw material volatility. Real-time production monitoring, maintenance scheduling, and QA-supported inventory management form the backbone of our supply continuity practices. The core capacity can be reassigned dynamically across 2-Hydroxyvalerate grades as end-market order structures shift. Batch tracking and order bundle management minimize risk of allocation disruption, particularly for high-specification customers.
Sample requests initiate a controlled trial protocol. The technical service team evaluates the required grade, intended application, and specification reference. Pre-shipment documentation covers batch origin, analytical support, and storage or handling recommendations tailored to both quantity and process environment at the customer site. Feedback from initial product trials closes the loop, informing both product development and ongoing support, especially as customer requirements evolve.
Transactional arrangements flex to fit procurement planning cycles—spot purchase, framework agreement, or annual contract. Spec-driven supply can trigger on-demand production schedule, dedicated batch allocation, or stock reservation in line with customer preference. Partner companies with project-based or evolving specification needs gain access to adaptive documentation, custom packing, and logistics handling, reducing transaction complexity. This approach allows downstream users in sectors such as bioprocessing, advanced materials, or specialty intermediates to stay responsive, with manufacturer support that covers raw material shifts, volume variation, and compliance assurance without production interruption.
Research efforts on 2-hydroxyvalerate increasingly focus on bio-based production pathways. Enzyme-catalyzed transformations, fermentation optimization, and engineered microbial strains continue to drive interest as demand rises for intermediate chemicals with better environmental profiles. Production teams observe that yield optimization and feedstock flexibility hold persistent technical attention, especially as sugar or biomass sources shift by region. High-purity 2-hydroxyvalerate grades remain an R&D focus in applications requiring stringent control over trace side-products.
The scope for downstream application broadens as new polyhydroxyalkanoate copolymers and biodegradable resin formulations adopt 2-hydroxyvalerate as a structural building block. Lab support staff routinely field inquiries on compatibility in custom polymerization systems, food packaging, and medical-grade bioplastics due to changing regulatory and end-use mandates. Process optimization for material properties like thermal stability, barrier function, and degradation rate now shapes formulation support.
Technical teams tackle batch-to-batch consistency and impurity management during purification, especially for electronic or medical-grade requirements. Synthesis by chemical or biotechnological routes introduces variable minor by-products, requiring in-process analytics and tailored refinement. Controlled crystallization, moisture management, and storage behavior surface as ongoing technical hurdles. Recent advances in enzyme immobilization and in-line purification enable lower energy input and improved selectivity for select routes, reducing downstream filtration demand.
Demand for 2-hydroxyvalerate is expected to track growth in bio-based polymer sectors, particularly in automotive, packaging, and medical materials. Expansion projects often coordinate with OEMs and compounders developing next-generation biodegradable products. Market teams plan capacity alignment to regional trends, noting that shifts in feedstock economics and waste valorization incentives may influence route selection and investment in production scale.
Process development groups prioritize modular, integrated production lines with real-time analytics for impurity control and flexible grade management. Continuous flow reactors and immobilized catalyst systems gain traction for their ability to tune output quality and reduce operational footprint. Route selection increasingly incorporates closed-loop water use and waste minimization. The feedback loop between polymer application requirements and chemical production encourages earlier concurrent engineering between end-users and technical staff.
Customer inquiries on carbon performance, renewable sourcing, and waste minimization intensify. Raw material selection increasingly favors agricultural byproducts and renewables over fossil-based input. Internal LCA analysis guides continuous improvement, informing solvent selection, energy use, and waste management strategies. Downstream partners expect documentation on renewable content, traceability, and eco-toxicity. Teams collaborate early with users to anticipate regulatory changes and optimize eco-footprint without compromising purity or performance requirements for target grades.
Process engineers and lab specialists handle application-specific technical queries, including impurity profile analysis, process adaptation support, and troubleshooting of scale-up runs. Consultation covers feedstock compatibility, purification bottlenecks, storage stability, and delivery condition requirements, adapting recommendations to site conditions or processing technology at the user’s facility.
Technical service teams facilitate formulation trials, polymerization compatibility, and process integration for bulk and specialty end-uses. Typical support ranges from on-site troubleshooting to joint R&D with film extruders or compounders, ensuring product properties meet user specs, whether for barrier films, medical devices, or other advanced material systems. Optimization strategies consider product grade, moisture management in storage, and downstream processing environment to prevent handling issues.
Quality control and customer care teams track performance feedback, with clear internal procedures for non-conformance review and root-cause investigation. Complaint follow-up involves joint analysis of supplied batch records, shipment conditions, and analytical data against agreed release criteria. Continuous improvement relies on structured user feedback, driving process refinement, training, and periodic customer technical reviews, especially as customer requirements evolve in regulated or specialty application fields.
As a chemical producer specializing in 2-hydroxyvalerate, factory teams oversee every stage in production. From raw material selection through synthesis, purification, and drying, shop floor supervision ensures the process meets occupational safety standards and technical requirements. Dedicated reactors and purification lines maintain batch integrity, cutting out risk of cross-contamination, which matters when downstream processes demand a predictable input profile.
Bulk volumes of 2-hydroxyvalerate move directly to industrial polymer labs, coatings plants, and specialty chemistry sectors. R&D groups in bioplastic production incorporate this chemical as a monomeric building block, contributing to side-chain variability and modifying polymer properties. Rigid process control at the manufacturing level minimizes risk for further processing, particularly where trace components or off-spec byproducts could interfere.
Paints, surface treatments, and adhesive production lines employ this molecule for its compatibility with water-based and specialty resin systems. Trace-metal content remains tightly monitored to protect catalysts and maintain stability in highly formulated end products. Downstream technical teams rely on the production floor’s consistent batch-to-batch supply; unplanned deviations can disrupt continuous operations.
Onsite labs maintain daily analysis of each output lot using advanced chromatography and wet-chemistry methods. Comparison with internal reference standards tracks purity and checks for residual solvents or process impurities. In-house technical teams review precise analytical trends, intervening promptly in the event of any drift. Clear labeling and transparent data sharing with customer technical teams shorten problem-solving cycles and underpin mutual trust.
Bulk 2-hydroxyvalerate ships directly from the factory in volumes appropriate to customer scale, using specialty containers suitable for chemical transport. Drum, intermediate bulk container, and tank truck loading take place under direct supervision to exclude contamination and avoid packaging errors. Documentation supports traceability from production. Logistics groups on site coordinate exit schedules, integrate with warehousing needs, and prioritize reliability for just-in-time supply chains.
Technical support specialists with practical production background work side-by-side with manufacturing customers. Advisory on compatibility, processing recommendations, and analytical methods is based on firsthand plant operation, not theoretical advice. Teams assist in trouble-shooting and onboarding new lines using field knowledge from previous industrial manufacturing runs. Support continues throughout long-term supply relationships, keeping pace with evolving process and regulatory requirements.
For procurement professionals, total cost of ownership hinges on supply confidence and process predictability. A factory-managed supply reduces risk from speculative market shifts, unknown intermediaries, or hidden process changes. Direct oversight of production, strict quality verification, and coordinated logistics support customer procurement planning, contract management, and operational budgeting. Manufacturers and distributors benefit from the transparency and application expertise that only direct producers deliver, feeding directly into competitive production and sustainable business outcomes.
Day in and day out, chemists on our production team put rigorous attention into monitoring the purity of every 2-Hydroxyvalerate batch before it leaves our facility. In industrial chemistry, the story of quality starts with purity—measuring true assay, identifying trace-level impurities, and understanding their origins. Customers rely on accurate content, so we operate our own internal labs with calibrated analytical instruments for everything from titration and chromatography to elemental analysis. Every batch receives a confirmed purity result before packaging.
We consistently achieve ≥99% assay for the main component, 2-Hydroxyvalerate. Our purification process uses fractional crystallization and advanced filtration to separate byproducts that can occur during synthesis, such as unreacted acids, secondary alcohols, or minor oligomeric residues. Production runs are mapped against strict specifications: color, odor, and turbidities are checked visually, but most importantly, we measure the real assay using validated methods. We also routinely screen for common organic and inorganic impurities below 0.5% by weight—much lower in most final batches.
Source materials come from accountable, trackable chemical supply routes that support reliable outcomes. Every raw lot batch is re-confirmed before use, so inconsistent impurity loads never enter the process. All our reactors and handling lines feature inert surfaces and are subject to preventive maintenance. By minimizing iron or other transition metal contaminants, we don’t depend on scavenger additives in downstream processing. Our technical staff checks for elements such as sodium, potassium, and chloride at the ppm level, because even low concentrations can have a large impact for industries that take our material into catalysis, polymer, or pharmaceutical synthesis.
Trace water content is a frequent concern. Our in-process controls include both Karl Fischer titration and loss-on-drying tests. Through controlled atmospheric drying and sealed packaging, we guard the moisture level and make sure our standard grade arrives below 0.1% by weight H2O. Each production step produces real-time data so we can intervene promptly if a deviation occurs, rather than discovering a problem post-shipment. Technical teams review all data before approval for shipment.
Co-eluting organic acids, lactones, and other potential side products are common in organic acid synthesis. We test for these by GC-MS and HPLC. Most final lots deliver single-digit ppm levels or fall below our detection threshold, supporting downstream transformations that demand both precision and reproducibility. This level of control over purity allows formulators and researchers to trust data generated from our product.
We keep full batch documentation, so clients receive full traceability and data transparency with deliveries or upon request. If specifications for a process call for even higher purity, our team can discuss upgraded purification options or special runs. Our flexibility as a direct manufacturer means we answer technical questions based on hands-on experience, not from a catalog.
2-Hydroxyvalerate, made to tight purity standards, has grown important for specialty polymers, biodegradable surfactants, and fine chemical intermediates. We constantly invest in improving our detection and processing power because quality on the micro-scale turns into reliability for our customers on the macro-scale.
Industrial production requires packaging formats that align with efficiency, safety, and logistics. In our direct manufacturing facility, we handle 2-Hydroxyvalerate from synthesis to dispatch, so we know exactly what’s coming off our reactors and how it gets into your process. We receive a steady stream of questions about bulk packaging and minimum ordering for this product, so we’ll lay out our approach for these industrial scenarios.
Production output gets packed in formats engineered for scale. Our standard bulk options for 2-Hydroxyvalerate cover 200-liter HDPE drums and 1,000-liter Intermediate Bulk Containers (IBCs). These two vessels have proven the most practical and robust for handling materials in freight, giving enough mass per unit to streamline warehouse and transportation costs, but manageable enough for most plant infrastructures. Each container comes fully sealed, with tamper-evident closures and secondary spill protection—details matter when dealing with valuable intermediates.
Drums and IBCs not only support efficient handling, but also protect product integrity during their journey, whether we’re shipping across town or exporting by sea container. All our bulk packaging goes through regular integrity testing and compatibility checks with our in-house quality control team. Batch labels trace every lot straight back to its origin on our factory floor, which has helped our clients with tracking and audit documentation during compliance checks.
Clients running high-throughput operations sometimes look for non-standard packaging or logistical strategies—our technical team works directly with procurement and operations leads to tailor solutions. For sustained high-volume programs, our crew can review reusable container programs or custom tankers, provided project scales and site facilities can justify the investment. Such plans follow strict technical and regulatory vetting, with the goal always to avoid bottlenecks during offloading or material transfer. Our experience shows that investing in optimal packaging upfront reduces inventory shrinkage and minimizes plant downtime from unplanned material handling issues.
We calibrate our minimum order quantities to strike a balance between cost-efficient manufacturing and regular industrial demand. For 2-Hydroxyvalerate, our typical MOQ sits one full drum at a time—200 liters net. We set this threshold based on our batch processing runs, packaging logistics, and quality assurance requirements. For IBC orders, orders begin at one full IBC—1,000 liters net. These thresholds let us guarantee material traceability and packaging performance on every shipment.
Our customers often consolidate material needs across multiple sites or divisions, optimizing delivered quantity without incurring excess holding cost. From the manufacturing perspective, this aggregation helps us maintain stable production planning, which in turn supports cost predictability, on-time delivery, and competitive pricing.
Procuring chemical intermediates directly from a manufacturer gives clear traceability, predictable lead times, and a technical team that stands behind each lot number. Rather than passing along generalities, we maintain direct control over container quality, material handling protocols, and logistics support. If your team needs detailed documentation or specialized handling instructions, our regulatory and technical experts work alongside your site personnel to close any gaps in information.
Our industrial clients rely on bulk packaging done right, and our workflow reflects that reality from order to delivery. At the factory level, every drum or IBC filled meets our own internal standards for purity, segregation, safety, and traceability—our entire business model rests on it.
Moving chemical products like 2-Hydroxyvalerate across international and domestic borders involves a series of obligations, many of which center around safe transport and compliance. From raw material sourcing to the factory gate, and then through regional or global transit, our role includes preparing, packing, and shipping chemicals in line with government rules. Both the United States Department of Transportation (DOT) and the European ADR classification outline specific protocols for products shipped by road, sea, or air. Neglecting these requirements can lead to shipment delays or even regulatory sanctions, reducing trust and reliability in every sector that relies on steady supply chains.
At our facility, each batch of 2-Hydroxyvalerate is produced in accordance with good manufacturing practices. Compliance with transport regulations is verified at every step. Before dispatch, we assess whether the product falls under any hazmat categories per DOT or ADR. For 2-Hydroxyvalerate, recent regulatory reviews indicate it does not meet criteria for dangerous goods under standard transit conditions. Our records show no classification under flammable, toxic, or environmentally hazardous designations for this compound in its pure form. Still, we do not take shortcuts; packaging, labeling, and documentation are always aligned with the best available guidance.
We see the Safety Data Sheet (SDS) as the backbone of responsible chemical commerce. Our SDS for 2-Hydroxyvalerate includes key hazard information, physical and chemical properties, recommended handling protocols, personal protective equipment, and first-aid instructions. This documentation is not just issued as part of a file—it is sent physically and electronically with each shipment. The SDS undergoes periodic review so the content stays up to date with any regulatory revisions or changes in hazard classification. Multilingual versions are available, supporting international logistics and border clearance. All SDSs fulfill the requirements set by the Globally Harmonized System (GHS), OSHA 29 CFR 1910.1200, and REACH Annex II.
Transport rules differ by country and mode. Instead of leaving compliance up to the freight forwarder or customs agent, our own export officers manage the paperwork and double-check transport codes. This reduces the risk of container holds or added inspection at ports. Few things impact delivery schedules more than missing customs documents or inaccurate hazard declarations. Our logistics staff train regularly on new updates from IATA (air), IMO (sea), and ADR (road), which helps us adapt quickly if governments reclassify a substance or update carriage instructions.
Technology streamlines our workflow, but direct oversight from our plant personnel remains key. We audit our labeling and SDS production processes quarterly and run full mock shipments to ensure all customs, transport, and regulatory requirements are met without gaps. Any client with specialized documentation needs, or requests for compliance statements, receives timely responses from our product stewardship team. This direct connection between production, safety, and logistics keeps communication crisp and prevents third-party translation errors.
We take pride in shipping 2-Hydroxyvalerate in strict adherence to safety standards. Every step, from secure packaging selection to final documentation review, flows from policies created and implemented by our own technical and compliance experts. Customers can rely on full SDS packets and regulatory paperwork tailored for international transit, backed by staff who understand not just the product—but the rules that govern how it travels.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
